Accessibility Menu
 
Fresenius SE & Co logo

Fresenius SE & Co

(OTC) FSNUY

Current Price$12.92
Market Cap$28.88B
Since IPO (2011)+96%
5 Year+32%
1 Year+23%
1 Month-17%

Fresenius SE & Co Financials at a Glance

Market Cap

$28.88B

Revenue (TTM)

$22.33B

Net Income (TTM)

$1.14B

EPS (TTM)

$0.57

P/E Ratio

22.69

Dividend

$0.28

Beta (Volatility)

0.56 (Low)

Price

$12.92

Volume

124,774

Open

$12.93

Previous Close

$12.82

Daily Range

$12.76 - $13.10

52-Week Range

$9.78 - $33.93

FSNUY News

No articles available.

FSNUY: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Fresenius SE & Co

Industry

Healthcare Providers and Services

Employees

177,356

CEO

Michael Sen, MBA

Headquarters

Bad Homburg vor der Höhe, 61352, DE

FSNUY Financials

Key Financial Metrics (TTM)

Gross Margin

25%

Operating Margin

10%

Net Income Margin

5%

Return on Equity

7%

Return on Capital

7%

Return on Assets

3%

Earnings Yield

4.41%

Dividend Yield

0.02%

Payout Ratio

57.13%

Stock Overview

Market Cap

$28.88B

Shares Outstanding

2.25B

Volume

124.77K

Short Interest

0.00%

Avg. Volume

67.04K

Financials (TTM)

Gross Profit

$5.38B

Operating Income

$1.78B

EBITDA

$3.14B

Operating Cash Flow

$2.45B

Capital Expenditure

$923.00M

Free Cash Flow

$1.52B

Cash & ST Invst.

$2.05B

Total Debt

$13.58B

Fresenius SE & Co Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$5.47B

+2.0%

Gross Profit

$1.30B

-4.8%

Gross Margin

23.70%

N/A

Market Cap

$28.88B

N/A

Market Cap/Employee

$164.85K

N/A

Employees

175,202

N/A

Net Income

$343.21M

+5.3%

EBITDA

$768.23M

+1.5%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$11.21B

-7.9%

Accounts Receivable

$5.62B

+47.2%

Inventory

$2.58B

+1.4%

Long Term Debt

$10.83B

-5.6%

Short Term Debt

$2.75B

+48.9%

Return on Assets

2.69%

N/A

Return on Invested Capital

6.54%

N/A

Free Cash Flow

$450.25M

-8.3%

Operating Cash Flow

$747.36M

-4.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FMCQFFresenius Medical Care AG & Co. KGaA
$49.21+9.35%
CSLLYCSL Limited
$24.61+1.03%
SMMNYSiemens Healthineers AG
$21.23-0.05%
ESLOYEssilorLuxottica S.A.
$112.55+0.79%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$178.68+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.31-0.04%
TERNTerns Pharmaceuticals
$52.88+0.06%
TQQQProShares Trust - ProShares UltraPro Qqq
$44.28+0.02%

Questions About FSNUY

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.